← Companies|BioLife Solutions
BL

BioLife Solutions

BLFS·NASDAQBothell WAFounded 2002300 employees
Small CapbiotechPublicOncology
Platform: CryoStor BioPreserv
Market Cap
$0.5B
All Drugs
2
Clinical Trials
5
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (BLFS)
Loading BLFS stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
ZanufotisoranBLF-8023Approved3Small MoleculePLK4MDM2iNSCLC
TeralucimabBLF-6835Phase 12Cell TherapyCD19Cl18.2MelanomaAS
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)
2026-05-20
Teralucimab Enrollment Complete
Melanoma
Enrollment Complete
2027-04-26
Teralucimab Interim
AS
Interim
2027-11-01
Zanufotisoran Ph3 Readout
NSCLC
Ph3 Readout
2031-01-19
Zanufotisoran Ph3 Readout
NSCLC
Ph3 Readout
2031-04-14
Zanufotisoran Ph3 Readout
NSCLC
Ph3 Readout